Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Due to risks for decreased bioavailability of birth control pills, the manufacturer of Mounjaro (tirzepatide) recommends that patients either use barrier contraception for four weeks after initiation or dosage increase or switch to a non-oral contraceptive
It is indicated as an adjunct to diet and exercise, either as monotherapy when metformin is not tolerated or as an add-on therapy with other diabetes medications
You must be logged in to post a comment.
Presented for research literature review only Li JM et al
US$ 21.97
US$ 20.72
US$ 26.97
